Statistics for Xtant Medical Holdings (id:214 XTNT)

Valuation metrics

Market cap

64.97M

Enterprise value

99.98M

Trailing P/E (ttm)

75.11

Forward P/E

-15.61

PEG ratio

-15.61

Price/Sales (ttm)

0.59

Price/Book (mrq)

1.36

Enterprise Value/Revenue

0.90

Enterprise Value/EBITDA

-10.30

Overview

Shares outstanding

138.71M

Float

45.17M

Shares short

197.47K

% Held by insiders

0.08%

% Held by institutions

0.65%

Average volume (10 days)

123.20K

Average volume (90 days)

Price summary

52-Week low

0.43

52-Week high

1.45

52-Week change

-188.37%

Beta

0.38

50-Day moving average

0.59

200-Day moving average

0.78

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

February 14th, 2018

Ex-dividend date

Last split factor

2:1

Last split date

February 14th, 2018

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-3.00%

Operating margin

-9.84%

Operational effectiveness

Return on assets

-10.58%

Return on equity

-8.77%

Income statement

Revenue (ttm)

0.86

Revenue per share (ttm)

0.86

Quarterly revenue growth (yoy)

Gross profit (ttm)

55.47M

EBITDA

-9,704,000.00

Net income to common (ttm)

-3,333,000.00

Diluted EPS (ttm)

-0.01

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

5.38M

Total cash per share (mrq)

0.04

Total debt (mrq)

34.99M

Total Debt/Equity (mrq)

77.74

Current ratio (mrq)

243.60%

Book value per share (mrq)

0.34

Cash flow

Cash flow statement

-15,592,000.00

Levered free cash flow (LFCF)

-28,139,500.00